Difference in activated partial thromboplastin time values with two different reagents according to C-reactive protein values

Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020...

Full description

Saved in:
Bibliographic Details
Published inLaboratory medicine Vol. 56; no. 1; pp. 7 - 14
Main Authors Ishihara, Yuya, Doi, Hiroki, Sato, Seiko, Ito, Hiroyasu
Format Journal Article
LanguageEnglish
Published England Oxford University Press 06.01.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical). A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine. This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background.
AbstractList Background Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. Method This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical). Results A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine. Conclusion This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient’s background.
Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies. This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical). A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine. This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background.
Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies.BACKGROUNDActivated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine the cause of discrepancies.This study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical).METHODThis study included 18,994 subjects who underwent coagulation tests at our hospital from May 2020 to December 2020. Measuring reagents included HemosIL SynthASil APTT (APTT-SS, Instrumentation Laboratory) and Coagpia APTT-N (APTT-N, Sekisui Medical).A total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine.RESULTSA total of 451 patients demonstrated APTT-N of >39 seconds and an APTT-N/SS ratio of >1.3. A C-reactive protein (CRP) level of ≥1.4 mg/L demonstrated a significant positive correlation, with a higher APTT-N/SS indicating higher CRP levels. All 28 subjects receiving no anticoagulants and who had remaining specimens underwent a cross-mixing test (CMT). Of them, 17 were suspected for lupus anticoagulant (LA) by both the waveform shape and the index of circulating anticoagulant (ICA) value, 6 by the ICA value, and 5 were difficult to determine.This study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background.CONCLUSIONThis study revealed that the APTT-N prolongation correlated with CRP degree and the transient involvement of LA in CMT results due to CRP. This study indicated various reactivities depending on the assay reagents used. Further testing is warranted if LA is suspected, considering the patient's background.
Author Ishihara, Yuya
Doi, Hiroki
Sato, Seiko
Ito, Hiroyasu
Author_xml – sequence: 1
  givenname: Yuya
  surname: Ishihara
  fullname: Ishihara, Yuya
– sequence: 2
  givenname: Hiroki
  surname: Doi
  fullname: Doi, Hiroki
– sequence: 3
  givenname: Seiko
  surname: Sato
  fullname: Sato, Seiko
– sequence: 4
  givenname: Hiroyasu
  surname: Ito
  fullname: Ito, Hiroyasu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39213365$$D View this record in MEDLINE/PubMed
BookMark eNpdkT1v2zAQhonCQe0kXTsWBLpkkXP8EsWxcJukQIAsySzQ1ClhIIkuSTvo0P8eCnY7dDrc4cFzh3vPyWIKExLymcGagRHXg92O2F0Po0VQ4gNZMSNFpbWABVkBgK4UcL0k5ym9llaamn8kS2E4E6JWK_Lnu-97jDg5pH6i1mV_sBk7urMxezvQ_BLDuA27waZcgOxHpAc77DHRN59faH4LtDs5Mo1on0tNReRC7Pz0THOgm6rMZzPSXQwZi-eouCRnvR0SfjrVC_J08-Nxc1fdP9z-3Hy7rxzXTa7QKKkMV7p20jSgamCuh0Ywq7a6EdZgB8i6WgvegN6CUrZvJHClXCMtl-KCXB29Zf2vsje3o08Oh8FOGPapFWBmr-R1Qb_-h76GfZzKda3gEmrGuJqFX07Ufv5_u4t-tPF3-_exBVgfARdDShH7fwiDdk6uPSbXnpIT706mjdM
Cites_doi 10.1172/JCI18921
10.1111/jth.15264
10.1136/jcp.38.2.133
10.1111/ijlh.12499
10.1111/joim.13126
10.1002/jcla.22415
10.1111/ijlh.13277
10.1002/jcla.24608
10.1007/s11239-021-02591-4
10.2147/JBM.S273047
10.1111/j.1365-2141.2011.08990.x
10.1056/NEJMc2013656
10.1055/s-0041-1729856
10.1002/art.10187
10.1155/2014/320674
10.1111/j.1538-7836.2006.01753.x
10.1016/j.ab.2009.04.037
10.5847/wjem.j.1920-8642.2011.01.014
10.1111/jth.13243
10.1002/rth2.12245
10.1111/ijlh.14003
10.1186/s12877-022-03327-6
10.1056/NEJMra1705454
10.1002/rth2.12090
10.1111/jth.15047
10.1111/j.1538-7836.2012.04906.x
10.1016/j.jtha.2022.11.011
10.1111/j.1365-2516.2009.02108.x
10.1002/jcla.22571
10.1093/labmed/lmx050
10.1111/jth.14980
10.1007/s11926-009-0075-4
10.1002/rth2.12809
10.7759/cureus.8349
10.1046/j.1365-2141.1999.01596.x
10.1007/s11239-021-02485-5
10.1016/s0969-2126(99)80023-9
10.1136/jcp.49.1.10
10.1016/j.clinbiochem.2022.01.010
ContentType Journal Article
Copyright The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Copyright_xml – notice: The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
DBID AAYXX
CITATION
NPM
K9.
NAPCQ
7X8
DOI 10.1093/labmed/lmae053
DatabaseName CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1943-7730
EndPage 14
ExternalDocumentID 39213365
10_1093_labmed_lmae053
Genre Journal Article
GroupedDBID ---
04C
0R~
4.4
48X
5GY
5WD
6PF
7RV
7X7
AABZA
AACZT
AAILS
AAMVS
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
AAWTL
AAYXX
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABNHQ
ABPPZ
ABPQP
ABPTD
ABQNK
ABVGC
ABWST
ABXVV
ACGFS
ACUFI
ACYHN
ADBBV
ADCFL
ADGZP
ADHKW
ADIPN
ADNBA
ADQBN
ADRTK
ADVEK
AEHKS
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGORE
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AJBYB
AJEEA
AJNCP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
ATGXG
AVWKF
BAYMD
BCRHZ
BENPR
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CITATION
CS3
DAKXR
DILTD
DU5
EBS
ENERS
EX3
F5P
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
IAO
J21
JXSIZ
KOP
KQ8
KSI
KSN
MHKGH
NAPCQ
NOMLY
NOYVH
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
PAFKI
PEELM
ROX
ROZ
RUSNO
TEORI
TJX
TPV
TR2
TWZ
WH7
WOW
YAYTL
YHZ
YKOAZ
YROCO
YXANX
NPM
K9.
7X8
ID FETCH-LOGICAL-c278t-e954592576c49805601cf0831a5b783a9ed0e1d6732807b055af840255c84a243
ISSN 0007-5027
1943-7730
IngestDate Fri Jul 11 12:02:44 EDT 2025
Wed Aug 20 03:11:07 EDT 2025
Thu Apr 03 06:59:59 EDT 2025
Tue Jul 01 03:32:57 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords C-reactive protein
lupus anticoagulant
phospholipid
activated partial thromboplastin time
coagulation
APTT prolongation
Language English
License https://academic.oup.com/pages/standard-publication-reuse-rights
The Author(s) 2024. Published by Oxford University Press on behalf of American Society for Clinical Pathology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c278t-e954592576c49805601cf0831a5b783a9ed0e1d6732807b055af840255c84a243
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 39213365
PQID 3240611254
PQPubID 105466
PageCount 8
ParticipantIDs proquest_miscellaneous_3099805426
proquest_journals_3240611254
pubmed_primary_39213365
crossref_primary_10_1093_labmed_lmae053
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-Jan-06
PublicationDateYYYYMMDD 2025-01-06
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-Jan-06
  day: 06
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chicago
PublicationTitle Laboratory medicine
PublicationTitleAlternate Lab Med
PublicationYear 2025
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Trimaille (2025010605545442200_CIT0038) 2022; 53
Wu (2025010605545442200_CIT0010) 2022; 22
Kim (2025010605545442200_CIT0040) 2022; 45
Kitchen (2025010605545442200_CIT0015) 1996; 49
Pineton de Chambrun (2025010605545442200_CIT0034) 2021; 289
Favaloro (2025010605545442200_CIT0039) 2022; 48
Kumano (2025010605545442200_CIT0021) 2019; 3
Garcia (2025010605545442200_CIT0030) 2018; 378
Harzallah (2025010605545442200_CIT0035) 2020; 18
Yasui (2025010605545442200_CIT0024) 2022; 36
Pepys (2025010605545442200_CIT0025) 2003; 111
Adenaeuer (2025010605545442200_CIT0003) 2023; 21
Toulon (2025010605545442200_CIT0016) 2016; 38
Cervera (2025010605545442200_CIT0029) 2002; 46
Chen (2025010605545442200_CIT0009) 2011; 2
Krone (2025010605545442200_CIT0032) 2010; 12
Winter (2025010605545442200_CIT0001) 2017; 48
Thompson (2025010605545442200_CIT0026) 1999; 7
Wilmot (2025010605545442200_CIT0019) 2020; 42
Christopeit (2025010605545442200_CIT0027) 2009; 391
Fliervoet (2025010605545442200_CIT0014) 2022; 104
Liu (2025010605545442200_CIT0023) 2018; 32
Devreese (2025010605545442200_CIT0033) 2020; 18
Bowles (2025010605545442200_CIT0036) 2020; 383
Kumano (2025010605545442200_CIT0012) 2012; 10
(2025010605545442200_CIT0011) 1985; 38
Ay (2025010605545442200_CIT0005) 2010; 16
Toulon (2025010605545442200_CIT0018) 2021; 19
Ng (2025010605545442200_CIT0031) 2018; 2
Jacobs (2025010605545442200_CIT0006) 2022; 53
De Jong (2025010605545442200_CIT0004) 2016; 14
Miyakis (2025010605545442200_CIT0028) 2006; 4
Yasin (2025010605545442200_CIT0002) 2020; 12
Kitchen (2025010605545442200_CIT0017) 1999; 106
Erez (2025010605545442200_CIT0007) 2022; 13
Noordermeer (2025010605545442200_CIT0037) 2022; 6
Sakurai (2025010605545442200_CIT0020) 2014; 2014
Falay (2025010605545442200_CIT0013) 2018; 32
van Rossum (2025010605545442200_CIT0022) 2012; 157
Neutze (2025010605545442200_CIT0008) 2016; 93
References_xml – volume: 111
  start-page: 1805
  issue: 12
  year: 2003
  ident: 2025010605545442200_CIT0025
  article-title: C-reactive protein: a critical update
  publication-title: J Clin Invest.
  doi: 10.1172/JCI18921
– volume: 19
  start-page: 2002
  issue: 8
  year: 2021
  ident: 2025010605545442200_CIT0018
  article-title: APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti-Xa reagent used for correlation
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.15264
– volume: 38
  start-page: 133
  issue: 2
  year: 1985
  ident: 2025010605545442200_CIT0011
  article-title: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control
  publication-title: J Clin Pathol.
  doi: 10.1136/jcp.38.2.133
– volume: 38
  start-page: 389
  issue: 4
  year: 2016
  ident: 2025010605545442200_CIT0016
  article-title: In vitro sensitivity of different activated partial thromboplastin time reagents to mild clotting factor deficiencies
  publication-title: Int J Lab Hematol.
  doi: 10.1111/ijlh.12499
– volume: 289
  start-page: 422
  issue: 3
  year: 2021
  ident: 2025010605545442200_CIT0034
  article-title: High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability
  publication-title: J Intern Med.
  doi: 10.1111/joim.13126
– volume: 32
  start-page: e22415
  issue: 6
  year: 2018
  ident: 2025010605545442200_CIT0013
  article-title: What should be the laboratory approach against isolated prolongation of a activated partial thromboplastin time
  publication-title: J Clin Lab Anal.
  doi: 10.1002/jcla.22415
– volume: 42
  start-page: 810
  issue: 6
  year: 2020
  ident: 2025010605545442200_CIT0019
  article-title: The traceability of commercial plasma calibrators to the plasma international standards for factor VIII and factor IX
  publication-title: Int J Lab Hematol.
  doi: 10.1111/ijlh.13277
– volume: 36
  start-page: e24608
  issue: 9
  year: 2022
  ident: 2025010605545442200_CIT0024
  article-title: Comparative analysis on characteristics of two activated partial thromboplastin time reagents
  publication-title: J Clin Lab Anal.
  doi: 10.1002/jcla.24608
– volume: 53
  start-page: 945
  issue: 4
  year: 2022
  ident: 2025010605545442200_CIT0006
  article-title: Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient
  publication-title: J Thromb Thrombolysis.
  doi: 10.1007/s11239-021-02591-4
– volume: 13
  start-page: 21
  issue: 1
  year: 2022
  ident: 2025010605545442200_CIT0007
  article-title: DIC in pregnancy – pathophysiology, clinical characteristics, diagnostic scores, and treatments
  publication-title: J Blood Med
  doi: 10.2147/JBM.S273047
– volume: 157
  start-page: 394
  issue: 3
  year: 2012
  ident: 2025010605545442200_CIT0022
  article-title: False prolongation of the activated partial thromboplastin time (aPTT) in inflammatory patients: interference of C-reactive protein
  publication-title: Br J Haematol.
  doi: 10.1111/j.1365-2141.2011.08990.x
– volume: 383
  start-page: 288
  issue: 3
  year: 2020
  ident: 2025010605545442200_CIT0036
  article-title: Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMc2013656
– volume: 48
  start-page: 55
  issue: 1
  year: 2022
  ident: 2025010605545442200_CIT0039
  article-title: Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature
  publication-title: Semin Thromb Hemost.
  doi: 10.1055/s-0041-1729856
– volume: 46
  start-page: 1019
  issue: 4
  year: 2002
  ident: 2025010605545442200_CIT0029
  article-title: Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
  publication-title: Arthritis Rheum.
  doi: 10.1002/art.10187
– volume: 2014
  start-page: 320674
  year: 2014
  ident: 2025010605545442200_CIT0020
  article-title: Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder
  publication-title: J Immunol Res
  doi: 10.1155/2014/320674
– volume: 4
  start-page: 295
  issue: 2
  year: 2006
  ident: 2025010605545442200_CIT0028
  article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2006.01753.x
– volume: 391
  start-page: 39
  issue: 1
  year: 2009
  ident: 2025010605545442200_CIT0027
  article-title: Characterization of Ca2+ and phosphocholine interactions with C-reactive protein using a surface plasmon resonance biosensor
  publication-title: Anal Biochem.
  doi: 10.1016/j.ab.2009.04.037
– volume: 2
  start-page: 73
  issue: 1
  year: 2011
  ident: 2025010605545442200_CIT0009
  article-title: Treatment of vitamin K-dependent coagulation factor deficiency and subarachnoid hemorrhage
  publication-title: World J Emerg Med
  doi: 10.5847/wjem.j.1920-8642.2011.01.014
– volume: 14
  start-page: 449
  issue: 3
  year: 2016
  ident: 2025010605545442200_CIT0004
  article-title: Developments in the diagnostic procedures for von Willebrand disease
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.13243
– volume: 3
  start-page: 695
  issue: 4
  year: 2019
  ident: 2025010605545442200_CIT0021
  article-title: Ruling out lupus anticoagulants with mixing test–specific cutoff assessment and the index of circulating anticoagulant
  publication-title: Res Pract Thromb Haemost
  doi: 10.1002/rth2.12245
– volume: 45
  start-page: 163
  issue: 2
  year: 2022
  ident: 2025010605545442200_CIT0040
  article-title: Lupus anticoagulants as a prospective independent predictor in COVID-19 patients
  publication-title: Int J Lab Hematol.
  doi: 10.1111/ijlh.14003
– volume: 93
  start-page: 279
  issue: 4
  year: 2016
  ident: 2025010605545442200_CIT0008
  article-title: Clinical evaluation of bleeding and bruising in primary care
  publication-title: Am Fam Physician.
– volume: 22
  start-page: 628
  issue: 1
  year: 2022
  ident: 2025010605545442200_CIT0010
  article-title: Neglected vitamin K deficiency causing coagulation dysfunction in an older patient with pneumonia: a case report
  publication-title: BMC Geriatr.
  doi: 10.1186/s12877-022-03327-6
– volume: 378
  start-page: 2010
  issue: 21
  year: 2018
  ident: 2025010605545442200_CIT0030
  article-title: Diagnosis and management of the antiphospholipid syndrome
  publication-title: N Engl J Med.
  doi: 10.1056/NEJMra1705454
– volume: 2
  start-page: 380
  issue: 2
  year: 2018
  ident: 2025010605545442200_CIT0031
  article-title: Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity
  publication-title: Res Pract Thromb Haemost
  doi: 10.1002/rth2.12090
– volume: 18
  start-page: 2828
  issue: 11
  year: 2020
  ident: 2025010605545442200_CIT0033
  article-title: Guidance from the Scientific and Standardization Committee for Lupus Anticoagulant/Antiphospholipid Antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.15047
– volume: 10
  start-page: 2338
  issue: 11
  year: 2012
  ident: 2025010605545442200_CIT0012
  article-title: APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2012.04906.x
– volume: 21
  start-page: 237
  issue: 2
  year: 2023
  ident: 2025010605545442200_CIT0003
  article-title: Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence
  publication-title: J Thromb Haemost.
  doi: 10.1016/j.jtha.2022.11.011
– volume: 16
  start-page: 111
  issue: 1
  year: 2010
  ident: 2025010605545442200_CIT0005
  article-title: Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women
  publication-title: Haemophilia
  doi: 10.1111/j.1365-2516.2009.02108.x
– volume: 32
  start-page: e22571
  issue: 8
  year: 2018
  ident: 2025010605545442200_CIT0023
  article-title: The analysis of false prolongation of the activated partial thromboplastin time (activator: silica): interference of C-reactive protein
  publication-title: J Clin Lab Anal.
  doi: 10.1002/jcla.22571
– volume: 48
  start-page: 295
  issue: 4
  year: 2017
  ident: 2025010605545442200_CIT0001
  article-title: Coagulation testing in the core laboratory
  publication-title: Lab Med.
  doi: 10.1093/labmed/lmx050
– volume: 18
  start-page: E3
  issue: 9
  year: 2020
  ident: 2025010605545442200_CIT0035
  article-title: Lupus anticoagulant is frequent in patients with Covid-19: response to reply
  publication-title: J Thromb Haemost.
  doi: 10.1111/jth.14980
– volume: 12
  start-page: 53
  issue: 1
  year: 2010
  ident: 2025010605545442200_CIT0032
  article-title: Impaired fibrinolysis in the antiphospholipid syndrome
  publication-title: Curr Rheumatol Rep.
  doi: 10.1007/s11926-009-0075-4
– volume: 6
  start-page: e12809
  issue: 6
  year: 2022
  ident: 2025010605545442200_CIT0037
  article-title: Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: a retrospective cohort study
  publication-title: Res Pract Thromb Haemost
  doi: 10.1002/rth2.12809
– volume: 12
  start-page: e8349
  issue: 5
  year: 2020
  ident: 2025010605545442200_CIT0002
  article-title: Diagnostic pearls and clinical implications of Prekallikrein deficiency
  publication-title: Cureus
  doi: 10.7759/cureus.8349
– volume: 106
  start-page: 801
  issue: 3
  year: 1999
  ident: 2025010605545442200_CIT0017
  article-title: Lipid composition of seven APTT reagents in relation to heparin sensitivity
  publication-title: Br J Haematol.
  doi: 10.1046/j.1365-2141.1999.01596.x
– volume: 53
  start-page: 228
  issue: 1
  year: 2022
  ident: 2025010605545442200_CIT0038
  article-title: Transient endothelial injury and release of lupus anticoagulant in COVID-19
  publication-title: J Thromb Thrombolysis.
  doi: 10.1007/s11239-021-02485-5
– volume: 7
  start-page: 169
  issue: 2
  year: 1999
  ident: 2025010605545442200_CIT0026
  article-title: The physiological structure of human C-reactive protein and its complex with phosphocholine
  publication-title: Structure.
  doi: 10.1016/s0969-2126(99)80023-9
– volume: 49
  start-page: 10
  issue: 1
  year: 1996
  ident: 2025010605545442200_CIT0015
  article-title: Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage
  publication-title: J Clin Pathol.
  doi: 10.1136/jcp.49.1.10
– volume: 104
  start-page: 30
  year: 2022
  ident: 2025010605545442200_CIT0014
  article-title: Comparison of capillary and venous blood sampling for routine coagulation assays
  publication-title: Clin Biochem.
  doi: 10.1016/j.clinbiochem.2022.01.010
SSID ssj0004962
Score 2.3304007
Snippet Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and determine...
Background Activated partial thromboplastin time (APTT) is susceptible to reagent composition. This study aimed to investigate a large number of specimens and...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 7
SubjectTerms Anticoagulants
C-reactive protein
Reagents
Title Difference in activated partial thromboplastin time values with two different reagents according to C-reactive protein values
URI https://www.ncbi.nlm.nih.gov/pubmed/39213365
https://www.proquest.com/docview/3240611254
https://www.proquest.com/docview/3099805426
Volume 56
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvCMZXYSAjIfFQhaWxnY9HtK3aoBtCaqW-RU7ismg0qboUNCSe-be5sx2nhYGAlyhyrUvq--X8O9t3R8jLEEiIr5LAK4bz3OPA37wsw7OuoVRMBnHhc4x3Pj0Lj6f87UzMer3vG6eW1k32Ov96bVzJ_2gV2kCvGCX7D5p1QqEB7kG_cAUNw_WvdHxoq5vkOvMHhih8lsggl9gXT5Gfr-pFVi-BITd4nrFcqAFm91Y2pq35UrsKKc0A6ONHHe8mc3RJdRxVPTjwoF0bxYHO6QByjIhNWjs2UML9-p83608uz0tMCq1t_frKzQKHtamXXa7qi9Kt80hd1QksWHlROwmmDXteSVOnpV2nCIRepwg7r_b6-Mct2xx5wjeZAlrbbJKOb2HQGNpoY8Y2Uai_zAUmTxZ8SwtcNh59Wkgsg9HNe-1e_9n7dDQdj9PJ0Wxyg9wMAK9YCuPdh42080lo0s7bV3TZP9m-kb9vpW-zm9-4LJq6TO6SO9bnoG8MgO6Rnqp2ya1Tq6j75FuHI1pW1OGIWhzRbRxRxBE1IKCIIwo4og5HtMURdTiiTU07HFGLIyviAZmOjiYHx54ty-HlQRQ3nkqAdSfoqOY8iX106fM5FqyTIotiJhNV-GpYhJgGyo8yXwg5jzn6rnnMZcDZQ7JT1ZV6TGjApBBC5UHBEx5lcZKxnGWKicJPFOdRn7xqhzNdmuwrqTk1wVIz8Kkd-D7Za0c7tV_oZco0XQUKz_vkhfsZ7CduislK1WvoAy4S_Akgqn3yyGjJPQp8hyFjoXjyZ-FPye0O8Htkp1mt1TOgqk32XMPoB2A0nkQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Difference+in+activated+partial+thromboplastin+time+values+with+two+different+reagents+according+to+C-reactive+protein+values&rft.jtitle=Laboratory+medicine&rft.au=Ishihara%2C+Yuya&rft.au=Doi%2C+Hiroki&rft.au=Sato%2C+Seiko&rft.au=Ito%2C+Hiroyasu&rft.date=2025-01-06&rft.pub=Oxford+University+Press&rft.issn=0007-5027&rft.volume=56&rft.issue=1&rft.spage=7&rft.epage=14&rft_id=info:doi/10.1093%2Flabmed%2Flmae053&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-5027&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-5027&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-5027&client=summon